Research URMC, RRH Join Pfizer and BioNTech Late-Stage COVID-19 Vaccine Study By Mark Michaud Jul. 28, 2020 The University of Rochester Medical Center (URMC) and Rochester Regional Health (RRH) are joining a phase 3 clinical trial for a potential coronavirus vaccine developed by Pfizer and BioNTech. Four ...
Research URMC Study Tests if COVID-19 Convalescent Plasma Can Treat, Prevent Infection By Susanne Pallo Jul. 23, 2020 URMC is joining two national clinical trials testing whether transfusions of plasma from recovered COVID-19 patients (also called convalescent plasma) can prevent infection in healthy volunteers or ...
Research URMC Receives $24 Million to Translate Research Discoveries into Health Improvements By URochester Medicine Communications Jul. 21, 2020 URMC has been awarded another $24.3 million from the National Institutes of Health to continue efforts to translate scientific discoveries into therapies that improve health. This is the fourth ...
Research Coordinating Coronavirus Research: Creating Options for Our Sickest COVID-19 Patients By Susanne Pallo Jul. 14, 2020 Since COVID-19 hit Rochester in March of 2020, a team of University of Rochester Medical Center clinicians and researchers has mobilized to bring the most promising clinical trials - that address the ...
Research URMC Launches Clinical Trials to Test Hydroxychloroquine in COVID-19 Patients By URochester Medicine Communications Jun. 2, 2020 A pair of national clinical trials testing whether hydroxychloroquine (HCQ), an FDA-approved anti-malarial drug, can keep COVID-19 patients alive and out of the hospital were halted on June 19, 2020. ...
Research Wilmot Leader Earns $1.5M Grant for Breakthrough Clinical Trial By Leslie Orr Jun. 1, 2020 David Linehan, M.D., chief of clinical operations at the Wilmot Cancer Institute, is the inaugural recipient of a $1.5 million award from Gateway for Cancer Research.
Research URMC, RRH Collaborating to Test Experimental Coronavirus Vaccine By Mark Michaud May. 5, 2020 The University of Rochester Medical Center (URMC) and Rochester Regional Health (RRH) are investigating a new potential coronavirus vaccine developed by Pfizer and BioNTech. “COVID-19 is a highly ...
Research New URMC Coronavirus Research Examines Immune Response By URochester Medicine Communications Apr. 16, 2020 The University of Rochester Medical Center (URMC) have launched a new study to understand how the body’s immune system responds to COVID-19, including if and when a person could be re-infected ...
Research URMC Begins Clinical Trial for New COVID-19 Treatment By URochester Medicine Communications Mar. 25, 2020 The University of Rochester Medical Center (URMC) is participating in a NIH-sponsored clinical trial to evaluate the safety and efficacy of the investigational antiviral drug remdesivir in ...
Education Wilmot Cancer Research Fellowship Supports ‘Trajectory of Learning’ By URochester Medicine Communications Jan. 30, 2020 Wilmot's support for education continues beyond formal medical and scientific training to professional development for faculty and staff. A special mechanism is devoted to this kind of ongoing ...
